Ecully, France · Founded 2003 · Privately Held (backing)
Manufacturer of pharmaceutical ingredients and specialty ingredients based in Ecully, France. Seqens is based in Ecully, France and was founded in 2003. Its last reported valuation was $1.6 billion in Nov 2022. It has raised $544 million.
Last reported valuation
$1.6B
Oct 2026
Priced at
—
Total raised
$543.8M
Last round
—
How much has Seqens raised?
$543.8Macross 0 recorded rounds
Free account
More of Seqens with a free account
·Watch Seqens: the Monday email on marks, rounds and moves